T
MACK

TradeWorx’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History

TradeWorx’s Portfolio MACK Stock Details MACK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		$135K Buy
+1,961
New +$105K 0.18% 201

Other funds holding MACK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

TradeWorx's MACK Position: Q3 2014 in Review

TradeWorx opened a new position in Merrimack Pharmaceuticals, Inc. (MACK) in Q3 2014: 1,961 shares worth $135K. The stake represents 0.18% of the portfolio and ranks #201 among its holdings.

132 funds tracked by Wall St. Rank hold MACK as of Q3 2014.

  • TradeWorx held 1,961 shares of Merrimack Pharmaceuticals, Inc. worth $135K as of Q3 2014.
  • Merrimack Pharmaceuticals, Inc. was a new TradeWorx position in Q3 2014.
  • Merrimack Pharmaceuticals, Inc. made up 0.18% of TradeWorx's portfolio in Q3 2014, its #201 holding.
  • 132 funds tracked by Wall St. Rank held Merrimack Pharmaceuticals, Inc. as of Q3 2014.

Based on TradeWorx's 13F filing for Q3 2014, filed 1 Oct 2014.